Combined Gene Therapy and Stem Cell Transplantation for SCI

Dr. Murray Blackmore W2W 2017 Miami

Research in the Blackmore Lab

Neurons depend on long axons to communicate with target cells. Neurons in the brain and spinal cord have almost no ability to regenerate axons that are disrupted by injury or disease, resulting in a devastating and permanent loss of function. On the other hand, many other types of neurons, including peripheral neurons, neurons in lower vertebrates, and embryonic neurons, can regenerate their axons robustly. What mechanisms allow regeneration in some types of neurons but prevent it in others? The goals of my research program are to 1) identify genes that explain differences in regenerative ability between different types of neurons and 2) manipulate gene expression in neurons to promote regenerative ability. To do so we compare gene expression in regenerating versus non-regenerating neurons, and then test the activity of differentially expressed genes in culture assays of axon outgrowth. Then, using viral-mediated gene delivery in a rodent model of spinal cord injury, we test the strongest candidate genes for the ability to promote axon growth in living animals. Ultimately we aim to develop gene therapies to promote the regrowth of axons in the injured spinal cord and brain.

This entry was posted in Chronic Spinal Cord Injury Research, Gene Therapy, Regenerative Medicine, spinal cord injury research and tagged . Bookmark the permalink.

3 Responses to Combined Gene Therapy and Stem Cell Transplantation for SCI

  1. Carolyn Young says:

    My son is a C5-C7. We appreciate and follow your research. We live in Virginia and want to know how we can help

  2. Elmar E. Bingcang says:

    I’m a t3t4 spinal cord injured patient. I’m hangin on every new development can can offer us some ray of hope that can liberate us from this prison called paralysis

Comments are closed.